1, 2 Di-substituted idopyranose from Vitex negundo L. Protects against streptozotocin-induced diabetes by inhibiting nuclear factor-kappa B and inducible nitric oxide synthase expression

Microscopy Research and Technique

Volumn 74, Issue 4, 2011, Pages 301-307

  Manikandan, Ramar ^a   Thiagarajan, Raman ^b   Beulaja, Sivagnanam ^c   Sivakumar, Mullaivanam Ramasamy ^c   Meiyalagan, Velayutham ^c   Sundaram, Ramalingam ^c   Arumugam, Munusamy ^c  

^a ALAGAPPA UNIVERSITY   (India)

^b SASTRA UNIVERSITY   (India)

^c UNIVERSITY OF MADRAS   (India)

Author keywords

Antidiabetic compound; Diabetes; Idopyranose; Inflammation; Vitex negundo

Indexed keywords

CELL MEMBRANES; CYTOLOGY; NITRIC OXIDE; PATHOLOGY;

ANTIDIABETIC; ANTIDIABETIC COMPOUND; DIABETIC MICE; HEPATOCYTES; IDOPYRANOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLAMMATION; NUCLEAR FACTORS; STREPTOZOTOCIN; VITEX NEGUNDO;

MAMMALS;

ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ENZYME INHIBITOR; HEXOSE; IDOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL; ARTICLE; CHEMISTRY; CYTOCHEMISTRY; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; KIDNEY; LIVER; MICROSCOPY; MOUSE; PANCREAS; PATHOLOGY; TREATMENT OUTCOME; VITEX;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; HEXOSES; HISTOCYTOCHEMISTRY; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; MICE; MICROSCOPY; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PANCREAS; TREATMENT OUTCOME; VITEX;

EID: 80755149968     PISSN: 1059910X     EISSN: 10970029     Source Type: Journal    
DOI: 10.1002/jemt.20904     Document Type: Article

References (34)

1. Alam MI, Gomes A. 2003. Snake venom neutralization by Indian medicinal plants (Vitex negundo and Emblica officinalis) root extracts. J Ethnopharmacol 86:75-80.
2. Bailey CJ, Day C. 1989. Traditional medicines in the treatment of diabetes. Diabetes Care 12:553-564.
3. Balazs M, Halmos T. 1985. Electron microscopic study of liver fibrosis associated with diabetes mellitus. Exp Pathol 27:153-162.
4. Baldwin AS, Jr. 1996. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 14:649-683.
5. Calabresi P, Chabner BA. 1991. Antineoblastic agents. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. The pharmacological basis of therapeutics, 8th edition. New York: Pergamon Press. pp.1209-1263.
6. Chawla AS, Sharma AK, Handa SS. 1992. Chemical investigation and anti-inflammatory activity of Vitex negundo seeds. J Nat Prod 55:163-167.
7. Das AV, Padayadtti PS, Paulose CS. 1996. Effect of leaf extract of Aegle marmelose (L) correa ex roxb on histological and ultrastructural changes in tissues of streptozotocin induced diabetic rats. Ind J Exp Biol 34:341-345.
8. Devi G, Falco A, Patrono C. 2005. Lipid peroxidation in diabetic mellitus. Antioxid Redox Signal 7:256-268.
9. Irene M, Villasenor MR, Lamadrid A. 2006. Comparative anti-hyperglycemic potentials of medicinal plants. J Ethnopharmacol 104: 129-131.
10. Kesari AN, Gupta RK, Singh SK, Diwakar S, Watal G. 2006. Hypoglycemic and hyperglycemic activity of Aegle marmelos seed extract in normal and diabetic rats. J Ethnopharmacol 107:374-379.
11. Lapolla A, Fedele D. 1993. Oxidative stress and diabetes: Role in the development of chronic complications. Minerva Endocrinol 18:99-108.
12. LaSelva M, Bettolamo E, Passera P, Porta M, Molinatti GM. 1993. The role of endothelium in the pathogenesis of diabetic microangiopathy. Acta Diabetol 30:190-200.
13. Leahy JL. 2005. Pathogenesis of type 2 diabetes mellitus. Arch Med Res 36:197-209.
14. Lee H, Han AR, Kim Y, Choi SH, Ko E, Lee NY, Jeong JH, Kim SH, Bae H. 2009. A new compound, 1H,8H-Pyrano[3,4-c]pyran-1,8-dione, suppresses airway epithelial cell inflammatory responses in a murine model of asthma. Int J Immunopathol Pharmacol 22:591-603.
15. Leonid EF, Philipson LH. 2004. Does the glucose-dependent insulin secretion mechanism itself cause oxidative stress in pancreatic b-cells? Diabetes 53:1942-1948.
16. Manikandan R, Sundaram R, Thiagarajan R, Sivakumar MR, Meiyalagan V, Arumugam M. 2009. Effect of black tea on histological and immunohistochemical changes in pancreatic tissues of normal and streptozotocin-induced diabetic mice (Mus musculus). Microscop Res Tech 72:723-726.
17. Manikandan R, Thiagarajan R, Beulaja S, Sudhandiran G, Arumugam M. 2010. Curcumin prevents free radical-mediated cataractogenesis through modulations in lens calcium. Free Rad Biol Med 48:483-492.
18. Marles RJ, Farnsworth NR. 1995. Antidiabetic plants and their active constituents. Phytomed 2:137-189.
19. Matsui M, Kumar-Roine S, Darius HT, Chinain M, Laurent D, Pauillac S. 2009. Characterisation of the anti-inflammatory potential of Vitex trifolia L. (Labiatae), a multipurpose plant of the Pacific traditional medicine. J Ethnopharmacol 126:427-433.
20. McCarty P, Zimmet P. 1997. Diabetes 1994-2010: Global estimate and projections. Diabetes Care 20:1785-1790.
21. Noor H, Hammonds P, Sutton R, Ashcroft SJ. 1989. Hypoglycemic and insulinotropic activity of Tinospora crispa: Studies with human and rats islets and HIT-T15 B cells. Diabetologia 32:354-359.
22. Perumalsamy R, Ignacimuthu S, Sen A. 1998. Screening of 34 Indian medicinal plants for antibacterial properties. J Ethnopharmacol 62:173-182.
23. Rahmy TR, EI-Ridi MR. 2002. Action of Anastatica hierochuntica plant extraction islets of langerhans in normal and diabetic rats. Egypt J Biol 4:87-94.
24. Shanmugasundaram ERB, Leela Gopinath K, Radha Shanmugasundaram K, Rajendaran VM. 1990. Possible regeneration of the islets of langerhans in streptozotocin diabetic rats given Gymnema sylvestre leaf extract. J Ethnopharmacol 30:265-279.
25. Srivastava SC, Sisodia CS. 1970. Analgesic studies on Vitex negundo and Valeriana wallichi. Ind Vet J 47:170-175.
26. Srivastava SK, Ramana KV, Bhatnagar A. 2005. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocrine 26:380-392.
27. Syed MA, Vrushabendra SBM, Gopkumar P, Dhanapal R, Chandrasekara VM. 2005. Anti-diabetic activity of Terminalia catappa Linn. leaf extract in alloxan induced diabetic rat. Iran J Pharmacol Therap 4:36-39.
28. Tak PP, Firestein GS. 2001. NF-κB: A key role in inflammatory diseases. J Clin Invest 107:7-11.
29. Telang RS, Chatterjee S, Varshneya C. 1999. Studies on analgesic and anti-inflammatory activities of Vitex negundo Linn. Ind J Pharmacol 31:363-366.
30. Umamaheswari M, Asokumar K, Somasundaram A, Sivashanmugam T, Subhadradevi V, Ravi TK. 2007. Xanthine oxidase inhibitory activity of some Indian medical plants. J Ethnopharmacol 109:547-551.
31. Woradulayapinij W, Soonthonhareonnon N, Wiwat C. 2005. In vitro HIV type1 reverse transcriptase inhibitory activities of Thai medicinal and Canna indica L. rhizome. J. Ethnopharmacol 101: 84-89.
32. World Health Organization. 1980. Expert committee on diabetes mellitus: Second report. Technical Report Series Number 646, World Health Organization, Geneva, p.61.
33. Zheng C-J, Huang B-K, Han T, Zhang QY, Zhang H, Rhaman K, Qin LP. 2009. Nitric oxide scavenging lignans from Vitex negundo seeds. J Natl Prod 72:1627-1630.
34. Zheng C-J, Huang B-K, Wang Y, Ye Q, Han T, Zhang QY, Zhang H, Qin LP. 2010. Anti-inflammatory diterpenes from the seeds of Vitex negundo. Bioorg Med Chem 18:175-181.